Loading...
Therapeutic approaches to target alpha-synuclein pathology
Starting two decades ago with the discoveries of genetic links between alpha-synuclein and Parkinson’s disease risk and the identification of aggregated alpha-synuclein as the main protein constituent of Lewy pathology, alpha-synuclein has emerged as the major therapeutic target in Parkinson’s disea...
Saved in:
| Published in: | Exp Neurol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6541231/ https://ncbi.nlm.nih.gov/pubmed/28987463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2017.10.003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|